Ad is loading...
LPTX
Price
$2.74
Change
-$0.15 (-5.19%)
Updated
Nov 15 closing price
RNXT
Price
$1.09
Change
-$0.00 (-0.00%)
Updated
Nov 15 closing price
One day until earnings call
Ad is loading...

LPTX vs RNXT

Header iconLPTX vs RNXT Comparison
Open Charts LPTX vs RNXTBanner chart's image
Leap Therapeutics
Price$2.74
Change-$0.15 (-5.19%)
Volume$322.36K
CapitalizationN/A
RenovoRx
Price$1.09
Change-$0.00 (-0.00%)
Volume$13.35K
CapitalizationN/A
LPTX vs RNXT Comparison Chart
Loading...
LPTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RNXT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
LPTX vs. RNXT commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LPTX is a Sell and RNXT is a Sell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (LPTX: $2.74 vs. RNXT: $1.09)
Brand notoriety: LPTX and RNXT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LPTX: 107% vs. RNXT: 37%
Market capitalization -- LPTX: $104.84M vs. RNXT: $26.15M
LPTX [@Biotechnology] is valued at $104.84M. RNXT’s [@Biotechnology] market capitalization is $26.15M. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LPTX’s FA Score shows that 0 FA rating(s) are green whileRNXT’s FA Score has 0 green FA rating(s).

  • LPTX’s FA Score: 0 green, 5 red.
  • RNXT’s FA Score: 0 green, 5 red.
According to our system of comparison, both LPTX and RNXT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LPTX’s TA Score shows that 4 TA indicator(s) are bullish while RNXT’s TA Score has 5 bullish TA indicator(s).

  • LPTX’s TA Score: 4 bullish, 7 bearish.
  • RNXT’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, RNXT is a better buy in the short-term than LPTX.

Price Growth

LPTX (@Biotechnology) experienced а -15.43% price change this week, while RNXT (@Biotechnology) price change was -4.39% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

LPTX is expected to report earnings on Aug 11, 2023.

RNXT is expected to report earnings on Feb 27, 2025.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LPTX($105M) has a higher market cap than RNXT($26.1M). LPTX YTD gains are higher at: -33.896 vs. RNXT (-52.402). RNXT has higher annual earnings (EBITDA): -10.27M vs. LPTX (-60.16M). LPTX has more cash in the bank: 78.5M vs. RNXT (11.7M). LPTX (0) and RNXT (0) have equivalent revenues.
LPTXRNXTLPTX / RNXT
Capitalization105M26.1M402%
EBITDA-60.16M-10.27M586%
Gain YTD-33.896-52.40265%
P/E RatioN/AN/A-
Revenue00-
Total Cash78.5M11.7M671%
Total Debt482KN/A-
FUNDAMENTALS RATINGS
LPTX: Fundamental Ratings
LPTX
OUTLOOK RATING
1..100
92
VALUATION
overvalued / fair valued / undervalued
1..100
47
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LPTXRNXT
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
83%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
84%
Advances
ODDS (%)
Bullish Trend 20 days ago
87%
Bullish Trend 10 days ago
86%
Declines
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
87%
Aroon
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
LPTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RNXT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ECPG49.220.83
+1.72%
Encore Capital Group
VRRM23.420.10
+0.43%
Verra Mobility Corp
ZS201.47-7.03
-3.37%
Zscaler
AKTX2.08-0.15
-6.73%
Akari Therapeutics plc
ZNTL3.47-0.48
-12.15%
Zentalis Pharmaceuticals

LPTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, LPTX has been loosely correlated with AXON. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if LPTX jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LPTX
1D Price
Change %
LPTX100%
-5.19%
AXON - LPTX
40%
Loosely correlated
-0.86%
AMRN - LPTX
35%
Loosely correlated
-3.85%
FBIO - LPTX
32%
Poorly correlated
-8.92%
ALLR - LPTX
30%
Poorly correlated
-6.38%
ARRY - LPTX
30%
Poorly correlated
-10.22%
More

RNXT and

Correlation & Price change

A.I.dvisor tells us that RNXT and BIOR have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RNXT and BIOR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RNXT
1D Price
Change %
RNXT100%
N/A
BIOR - RNXT
26%
Poorly correlated
-10.92%
SLNCF - RNXT
24%
Poorly correlated
N/A
MRKR - RNXT
24%
Poorly correlated
-12.29%
LPTX - RNXT
24%
Poorly correlated
-5.19%
PRLD - RNXT
24%
Poorly correlated
+0.97%
More